[1] Gao B,Bataller R. Alcoholic liver disease:pathogenesis and new therapeutic targets. Gastroenterology,2011,141(5):1572-1585. [2] Forbes SJ,Newsome PN. New horizons for stem cell therapy in liver disease. J Hepatol,2012,56(2):496-499. [3] Zhang Z,Wang FS. Stem cell therapies for liver failure and cirrhosis. J Hepatol,2013,59(1):183-185. [4] 王方,云升皓,周新人,等. 经肝动脉自体骨髓或脐带血干细胞移植治疗失代偿期肝硬化患者的安全性和近期疗效比较.实用肝脏病杂志,2014,17(4):356-359. [5] 沈建坤,郑联坵,潘兴南,等. 自体骨髓间充质干细胞治疗失代偿期酒精性肝硬化疗效分析. 实用肝脏病杂志,2015,18(6):628-632. [6] 郭屏,王淑平,刘丹萍. 川芎嗪联合促肝细胞生长素治疗慢性乙型病毒性肝炎肝纤维化疗效观察. 中国药房,2007,18(8):601-603. [7] Matsuda Y,Matsumoto K,Yamada A,et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology,1997,26(1):81-89. [8] 吴理茂,李连达,刘红,等. 自体脊髓干细胞移植与归元方连用治疗急慢性肝损伤实验研究. 中国工程科学,2004,6(8):34-38. [9] Yang L,Inokuchi S,Roh YS,et al. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.Gastroenterology,2013,144(5):1042-1054. |